Immune checkpoint inhibitors increase the risk of psoriasis

被引:0
|
作者
Nierengarten, Mary Beth
机构
关键词
D O I
10.1002/cncr.35753
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Psoriasis Risk With Immune Checkpoint Inhibitors
    To, Sheng-Yin
    Lee, Cho-Hao
    Chen, Yi-Hsien
    Hsu, Chia-Lu
    Yang, Hui-Wen
    Jiang, Ying-Shan
    Wen, Yuan-Liang
    Chen, I-Wen
    Kao, Li-Ting
    JAMA DERMATOLOGY, 2025, 161 (01) : 31 - 38
  • [5] Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors
    Cutroneo, Paola
    Ingrasciotta, Ylenia
    Isgro, Valentina
    Rullo, Emmanuele Venanzi
    Berretta, Massimiliano
    Fiorica, Francesco
    Trifiro, Gianluca
    Guarneri, Claudio
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [6] Do immune checkpoint inhibitors increase risk of NSAID and/or PPI renal toxicity?
    Bernier, M.
    Rocher, F.
    Andreani, M.
    Drici, M. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 60 - 60
  • [7] Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors
    Jfri, Abdulhadi
    Leung, Bonnie
    Said, Jordan T.
    Semenov, Yevgeniy
    LeBoeuft, Nicole R.
    IMMUNOTHERAPY ADVANCES, 2022, 2 (01):
  • [8] Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast
    Fattore, Davide
    Annunziata, Maria Carmela
    Panariello, Luigia
    Marasca, Claudio
    Fabbrocini, Gabriella
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : 107 - 109
  • [10] Cardiotoxicity risk factors with immune checkpoint inhibitors
    Zachary L. Brumberger
    Mary E. Branch
    Max W Klein
    Austin Seals
    Michael D. Shapiro
    Sujethra Vasu
    Cardio-Oncology, 8